Abstract

Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis

Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R

Issue: Jan/Feb 2010 - Pediatrics and Wellness

Page(s): 40-45

Download in electronic PDF format for $75
  • Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Page 1
  • Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Page 2
  • Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Page 3
  • Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Page 4
  • Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Page 5
  • Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Page 6

Abstract

The market for commercially manufactured drugs for pediatric patients is smaller than that for adults, and most of the medications currently used to treat children, including many over-the-counter products, have not been clinically studied in the pediatric population. Thus a customized medication that is formulated to meet the unique needs of the pediatric patient and that can be quickly adjusted to more effectively address a child’s changing medical needs can be essential to a successful therapeutic outcome. Compounding pharmacists are often faced with the demand for a novel pediatric preparation that overcomes the patient’s taste aversions or resistance to a particular dosage form, and successful treatment can depend on the compounder’s problem-solving skills and therapeutic innovation. In this article, we describe the effective treatment of three children whose medical needs were unmet by manufactured medications. The formulations for the preparations used are also provided.

Related Keywords

  • children
  • dosage forms
  • sildenafil suspension
  • pulmonary hypertension
  • case reports
  • formulations
  • biotin suspension
  • uncombable hair syndrome
  • Acanthamoeba keratitis
  • Baquacil ophthalmic solution
  • eye disorders
  • hair growth disorders
  • cardiovascular disorders
  • vision loss
  • eye pain

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • PEDIATRICS
  • CASE REPORTS
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2010
Pg. 40-45
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2013
Pg. 24-27
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Author(s): Wung Deanna
Nov/Dec 2006
Pg. 405-408
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals
Author(s): Davidson Gigi S
Jan/Feb 2012
Pg. 34-41
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Nov/Dec 2010
Pg. 488-491
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Author(s): Rudner Shara, Browne Paul
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
May/Jun 2016
Pg. 247-249
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Author(s): Nahata Milap C
May/Jun 2011
Pg. 194-199
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
Author(s): McElhiney Linda F
Mar/Apr 2010
Pg. 112-115
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient
Author(s): McElhiney Linda F
Jan/Feb 2009
Pg. 14-18
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jul/Aug 1997
Pg. 242-243
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease
Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
Nov/Dec 2022
Pg. 516-521
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
Mar/Apr 1997
Pg. 84-86
Compounding for the Pediatric Patient
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Jan/Feb 2007
Pg. 17-19
Pediatric Oral Formulations: A Continual Challenge
Author(s): Hurtado Josephine, Moffett Brady S
May/Jun 2007
Pg. 220-225
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2021
Pg. 24-28
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
Author(s): McElhiney Linda F
Jan/Feb 2017
Pg. 47-56
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Author(s): Akers Michael J
May/Jun 2010
Pg. 215-217
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report
Author(s): Muller George